Introduction:
The protection of intellectual property rights, particularly trademarks, plays a pivotal role in preserving the commercial identity, goodwill, and reputation of businesses and manufacturing entities. In the realm of specialized healthcare and medical devices, brand confusion can impact both commercial interests and public reliance on medical technology. The judgment under consideration arises from a trademark dispute in the medical equipment sector, addressing key principles governing interim injunctions, alleged descriptive trademarks, and the legal implications of pending rectification proceedings.
Factual and Procedural Background:
The applicant, a registered partnership firm, is an established manufacturer of specialized medical equipment, particularly in the fields of physiotherapy and electrotherapy. The applicant manufactures and markets its products under the trademark DIGILASER, which is a registered trademark under the relevant intellectual property laws.
The conflict emerged when the applicant discovered that another entity was manufacturing and selling medical devices under the trade name BMS DIGILASER PRO. The applicant noticed these products being offered for sale on online platforms. Upon bringing the matter to the attention of the relevant e-commerce intermediary, the infringing listings were removed from the online platform.
Subsequently, the respondents initiated a rectification application seeking the cancellation or removal of the applicant's registered trademark from the trade marks register. Additionally, the applicant filed a commercial suit seeking interim relief against trademark infringement and passing off. In the interim proceedings, the Court initially granted a interim injunction order on September 22, 2025. The matter was thereafter taken up for final hearing on the interim applications, leading to the decision delivered on July 31, 2026.
Dispute Before the Court
The primary legal and factual questions before the Court revolved around whether the respondent's adoption of the mark BMS DIGILASER PRO constituted an infringement and passing off of the applicant's registered trademark DIGILASER or HMS DIGILASER, and whether an interim injunction should be maintained during the pendency of the suit and the rectification proceedings.
The applicant contended that as the proprietor of a validly registered trademark, it enjoyed exclusive rights over the mark DIGILASER. The applicant argued that the respondent's mark DIGILASER PRO was deceptively similar to its registered mark and calculated to cause confusion among consumers and trade channels. To substantiate its legal rights, the applicant relied on settled judicial precedents protecting registered marks against unauthorized adoption.
In response, the respondents submitted that they had been engaged in the manufacture and supply of physiotherapy equipment since 2001 and had independently adopted the mark BMS DIGILASER-PRO in the year 2014. The respondents argued that the term DIGI refers to digital technology, LASER denotes laser-based treatment, and PRO signifies professional-grade equipment, making the phrase generic and descriptive in nature. The respondents claimed that no single entity could claim a monopoly over descriptive terms. Furthermore, the respondents urged that the addition of the prefix BMS clearly distinguished their product from the applicant's products. They also asserted that because the products are specialized medical devices purchased by trained healthcare professionals, hospitals, and rehabilitation centers rather than ordinary consumers, there was no likelihood of deception or confusion. Lastly, the respondents highlighted that they had applied for registration of their mark and filed a rectification application against the applicant's registration.
Reasoning and Analysis of the Court
In analyzing the rival contentions, the Court examined the statutory rights conferred on the owner of a registered trademark and evaluated the defense raised by the respondents. The Court observed that it was an admitted position that the applicant possessed a validly registered trademark. While the respondents argued that the term was descriptive and ought not to be monopolized, the Court highlighted a logical inconsistency in the respondents' stance: while questioning the registerability of the applicant's mark on descriptive grounds, the respondents had simultaneously applied for registration of their own similar trademark for exclusive rights.
The Court addressed the precedents cited by both parties. The applicant relied upon the Supreme Court ruling in Midas Hygiene Industries (P) Ltd. v. Sudhir Bhatia, reported in (2004) 3 SCC 92, to emphasize that an injunction must follow where there is a clear infringement of a registered mark. Reliance was also placed on N.R. Dongre v. Whirlpool Corp., reported in (1996) 5 SCC 714, and Parle Products (P) Ltd. v. J.P. & Co., reported in (1972) 1 SCC 618, regarding the principles of deceptive similarity and protection of brand equity. Conversely, the respondents cited J.R. Kapoor v. Micronix India, reported in 1994 Supp (3) SCC 215, Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd., reported in (2001) 5 SCC 73, and Pernod Ricard India Pvt. Ltd. v. Karanveer Singh Chhabra, reported in 2025 SCC OnLine SC 1701, to argue that specialized consumers and distinct prefixes prevent commercial deception.
The Court recognized the principle established by the Supreme Court that when there is no likelihood of confusion among end users, an action for infringement may fail. However, the Court carefully noted that whether the level of sophistication among professional buyers entirely eliminates consumer confusion is a factual matter that can only be conclusively determined after a full trial where evidence is led, rather than at the preliminary stage of an interim application.
Given the undisputed existence of the applicant's trademark registration and the pending rectification proceedings initiated by the respondent, the Court determined that the interim protection granted on September 22, 2025, ought to be affirmed to protect the applicant's prima facie statutory rights.
Final Decision of the Court
The Court made the ad-interim injunction granted on September 22, 2025, absolute pending the final disposal of the commercial suit. However, the Court explicitly clarified that this interim relief remains subject to the final outcome of the rectification petition pending between the parties. The Court disposed of Original Application Nos. 928 and 929 of 2025 without any order as to costs.
Point of Law Settled
This judgment reaffirms the principle that a registered trademark holder is entitled to interim protection against deceptively similar marks, even when the defendant contends that the mark is descriptive or used for specialized professional markets. The Court clarified that nuanced defenses—such as the target market consisting solely of sophisticated professionals or the mark being descriptive—require comprehensive evaluation during trial rather than serving as absolute bars to interim relief at the preliminary stage. Furthermore, the decision underscores that a party claiming a mark is generic cannot easily reconcile that defense with its own attempt to register the same mark.
Case Details:
Title of the Case: HMS Medical Systems Vs. B. Jayamani and Another
Date of Judgment: July 31, 2026
Case Number: O.A. Nos. 928 & 929 of 2025 in C.S. (COMM. DIV.) No. 238 of 2025
Neutral Citation: Not Available in Original Text
Name of Court: High Court of Judicature at Madras
Name of Hon'ble Judge: Hon'ble Mr. Justice K. Kumaresh Babu
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Disclaimer: Readers are advised not to treat this as a substitute for legal advice as it may contain errors in perception, interpretation, and presentation.
Headnote of the Judgment:
In M/s. HMS Medical Systems v. B. Jayamani and Another, before the High Court of Judicature at Madras (O.A. Nos. 928 & 929 of 2025 in C.S. (COMM. DIV.) No. 238 of 2025, decided on July 31, 2026), the registered trademark owner of DIGILASER sought an ad-interim injunction against the respondents for using the mark BMS DIGILASER PRO on medical equipment. The respondents claimed the term was descriptive and targeted specialized healthcare professionals, while also filing a rectification petition against the mark. The High Court held that questions regarding professional market confusion require full trial and made the interim injunction absolute, subject to the result of the rectification proceedings.
Suggested SEO Tags:
Madras High Court, Trademark Infringement, Passing Off, Interim Injunction, Medical Equipment Trademark, Deceptive Similarity, Descriptive Mark Defense, Rectification Proceedings, Intellectual Property Law, Trade Marks Act, AdvocateAjayAmitabhSuman, IPAdjutor
Suggested SEO Titles:
- Madras High Court Upholds Interim Injunction in DIGILASER Trademark Dispute
- Trademark Infringement vs Descriptive Terms: Analysis of Madras High Court Ruling
- HMS Medical Systems v. B. Jayamani: Legal Analysis on Trademark Rights
- Interim Relief in Trademark Law: How Courts Evaluate Deceptive Similarity
- Professional Market Exception in Trademark Cases: Madras High Court Analysis
- Impact of Pending Rectification Proceedings on Trademark Interim Injunctions
- Medical Device Trademarks and Brand Protection under Indian Law
- Can a Descriptive Term Be Monopolized? Madras High Court Decides
- Prima Facie Rights of Registered Trademark Holders in Interim Injunction Suits
- Madras High Court Clarifies Standard of Confusion at Preliminary Injunction Stage
Title of the Case is M/s. HMS Medical Systems v. B. Jayamani and Another, Date of Judgment is July 31, 2026, Case Number is O.A. Nos. 928 & 929 of 2025 in C.S. (COMM. DIV.) No. 238 of 2025, Neutral Citation is Not Available in Original Text, Name of Court is High Court of Judicature at Madras, and Name of Hon'ble Judge is Hon'ble Mr. Justice K. Kumaresh Babu.
No comments:
Post a Comment